| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acquired von Willebrand syndrome in monoclonal gammopathy – A scoping review on hemostatic management
|
Abou‐Ismail, Mouhamed Yazan
|
|
|
5 |
2 |
p. 356-365
|
artikel
|
| 2 |
Caging the dragon: Research approach to COVID‐19–related thrombosis
|
Kruip, Marieke J.H.A.
|
|
|
5 |
2 |
p. 278-291
|
artikel
|
| 3 |
Direct oral anticoagulants for unusual‐site venous thromboembolism
|
Riva, Nicoletta
|
|
|
5 |
2 |
p. 265-277
|
artikel
|
| 4 |
DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
|
Baker, Steven Andrew
|
|
|
5 |
2 |
p. 314-325
|
artikel
|
| 5 |
Emicizumab in tolerized patients with hemophilia A with inhibitors: A single‐institution pediatric cohort assessing inhibitor status
|
Batsuli, Glaivy
|
|
|
5 |
2 |
p. 342-348
|
artikel
|
| 6 |
Extended half‐life factor VIII concentrates in adults with hemophilia A: Comparative pharmacokinetics of two products
|
Teitel, Jerome
|
|
|
5 |
2 |
p. 349-355
|
artikel
|
| 7 |
Harnessing Twitter to empower scientific engagement and communication: The ISTH 2020 virtual congress experience
|
Othman, Maha
|
|
|
5 |
2 |
p. 253-260
|
artikel
|
| 8 |
Heavy menstrual bleeding in women on anticoagulant treatment for venous thromboembolism: Comparison of high‐ and low‐dose rivaroxaban with aspirin
|
Boonyawat, Kochawan
|
|
|
5 |
2 |
p. 308-313
|
artikel
|
| 9 |
In Memory of Professor Guy Meyer, 1957–2020
|
Emmerich, Joseph
|
|
|
5 |
2 |
p. 366-367
|
artikel
|
| 10 |
Issue Information
|
|
|
|
5 |
2 |
p. i, 249-252
|
artikel
|
| 11 |
Primary prophylaxis of venous thromboembolic disease with direct oral anticoagulants in patients with severe inherited thrombophilia
|
Krumb, Evelien
|
|
|
5 |
2 |
p. 261-264
|
artikel
|
| 12 |
Provoked versus unprovoked venous thromboembolism: Findings from GARFIELD‐VTE
|
Ageno, Walter
|
|
|
5 |
2 |
p. 326-341
|
artikel
|
| 13 |
The psychological impact of pulmonary embolism: A mixed‐methods study
|
Tran, Anna
|
|
|
5 |
2 |
p. 301-307
|
artikel
|
| 14 |
Validation of the IMPROVE‐DD risk assessment model for venous thromboembolism among hospitalized patients with COVID‐19
|
Spyropoulos, Alex C.
|
|
|
5 |
2 |
p. 296-300
|
artikel
|
| 15 |
Vascular thromboembolic events following COVID‐19 hospital discharge: Incidence and risk factors
|
Eswaran, Harish
|
|
|
5 |
2 |
p. 292-295
|
artikel
|
Tijdschrift beschrijving